Verastem, Inc. (VSTM)
5.93
-0.01
(-0.17%)
USD |
NASDAQ |
Feb 20, 16:00
5.935
0.00 (0.00%)
After-Hours: 20:00
Verastem SG&A Expense (Quarterly) : 21.01M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| CorMedix, Inc. | 36.64M |
| Anavex Life Sciences Corp. | 2.126M |
| ADMA Biologics, Inc. | 23.05M |
| Ocugen, Inc. | 8.228M |
| Zevra Therapeutics, Inc. | 16.94M |